Navigation Links
Keystone Symposia to hold conference in Seattle on immunological mechanisms of vaccination
Date:8/24/2010

SILVERTHORNE, CO, August 24, 2010 Keystone Symposia on Molecular and Cellular Biology will convene its conference on "Immunological Mechanisms of Vaccination" in Seattle, Washington from October 27 to November 1, 2010 at Sheraton Seattle Hotel. This is the first conference of Keystone Symposia's 40th meeting season and its first in Seattle. It will be held at the conclusion of the Grand Challenges in Global Health conference, also taking place in Seattle for that program's grant recipients earlier in the week.

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, the meeting will begin with keynote addresses on the evening of October 27, 2010 by Anthony S. Fauci of NIH and Tadataka Yamada of Bill & Melinda Gates Foundation, as well as a joint reception with the Grand Challenges in Global Health conference attendees.

Additional speakers over the course of the following four days will include Rafi Ahmed of Emory University School of Medicine, Norman Baylor of the US FDA, Robert L. Coffman of Dynavax Technologies, Stefan H.E. Kaufmann of Max Planck Institute for Infection Biology, Lalita Ramakrishnan of the University of Washington and many others. Concluding remarks on the evening of October 31 will be delivered by Peter C. Doherty of the University of Melbourne, one of two 1996 winners of the Nobel Prize in Medicine or Physiology for discovering how white blood cells recognize and kill virus-infected cells.

The four-day conference will bring together more than 400 researchers from around the world confronting a range of different diseases that would benefit from vaccine development. Included among the attendees will be 58 researchers and students originating from 27 developing countries who have received Keystone Symposia Global Health Travel Awards to attend the conference.

The goal of the meeting is to bring together, and encourage crosstalk between, vaccinologists, immunologists, virologists and systems biologists. Since these groups do not always interact, such interaction, it is hoped, will encourage the rational design of future vaccines against pandemics such as HIV, malaria and tuberculosis, and against emerging infections such as swine influenza and dengue. Because of recent advances in immunology, human genetics and systems biology particularly in our understanding of the role of innate immunity in shaping an adaptive immune response, the time is ripe for progress in this area.

The conference's scientific organizers are Bali Pulendran of Emory University, Rino Rappuoli of Novartis Vaccines & Diagnostics and Bruce A. Beutler of The Scripps Research Institute. Bali Pulendran is one of six scientists recently selected by the US Government to share $100 million over the next five years to conduct infectious disease and vaccination research.

Further information about the conference program can be found at keystonesymposia.org/10S1. Early registration, which saves US$100 on later registration fees, ends August 27, 2010. Late-breaking abstracts can still be submitted by e-mailing abstracts@keystonesymposia.org or calling 800-253-0685 (from US and Canada) or 970-262-1230.


'/>"/>

Contact: Yvonne Psaila
yvonnep@keystonesymposia.org
970-262-2676
Keystone Symposia on Molecular & Cellular Biology
Source:Eurekalert

Related biology news :

1. Keystone Symposia awarded $1.37 million, 5-year NIH grant to fund ongoing diversity efforts
2. Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative
3. Satellite symposia enhance scientific program with quality information and practical new knowledge
4. Symposia selected for Entomological Society of America meeting
5. BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule
6. Teleconference Alert: LyondellBasell Reviews Second Quarter 2010 Financial Results
7. University of Maryland co-sponsors International Conference on the Effects of Noise on Aquatic Life
8. AACR hosts cancer disparities conference in Miami, Fla.
9. BIO-key® International to Exhibit at Allscripts 2010 Client Experience Conference
10. AACR hosts molecular diagnostics conference in Denver, Colo.
11. Chances of hurricane hitting Texas discussed at UH conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/11/2017)... Georgia (PRWEB) , ... October 11, 2017 , ... Disappearing ... taking the lives of over 5.5 million people each year. Especially those living in ... greenovative startup Treepex - based in one of the most pollution-affected countries globally - ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
Breaking Biology Technology: